$TTRX
Turn Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$14.94
▲+8.10%+$1.12
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateTurn Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is TTRX up today? It is at $14.94 (+8.10%), and our scanner flagged it 22 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TTRX spikes, and full due diligence on TTRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $TTRX 22 times in the last 30 days. Create a free account to track $TTRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on TTRX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystTurn Therapeutics to Present at Stifel 2026, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Burnam Bradley Evan Officer | Sold (automatic/other) | -600K 2.0% of company | sold 3.8% | 15.12M | n/a | May 28, 26 |
Burnam Bradley Evan Officer | Acquired (grant/award) | +600K 2.0% of company | added 4.0% | 15.72M | n/a | May 28, 26 |
Golden Arthur F Director | Acquired (grant/award) | +300K 1.0% of company | added 100% | 361K | n/a | Apr 2, 26 |
Burnam Bradley Evan Officer | Sold (automatic/other) | -300K 1.0% of company | sold 1.9% | 15.72M | n/a | Apr 2, 26 |
Dewhurst Martin William Director | Acquired (grant/award) | +22K 0.07% of company | n/a | 22K | n/a | Jan 7, 26 |
Chaudhary Zuraiz Officer | Bought (open market) | +3K | added 25% | 13K | $9K at $3.50 | Dec 12, 25 |
Golden Arthur F Director | Bought (open market) | +10K 0.03% of company | added 19% | 61K | $34K at $3.44 | Nov 24, 25 |
Chaudhary Zuraiz Officer | Bought (open market) | +1K | added 11% | 10K | $3K at $3.29 | Nov 21, 25 |
Golden Arthur F Director | Bought (open market) | +21K 0.07% of company | added 68% | 51K | $59K at $2.87 | Nov 21, 25 |
Chaudhary Zuraiz Officer | Bought (open market) | +1K | added 19% | 9K | $4K at $2.61 | Nov 20, 25 |
Chaudhary Zuraiz Officer | Bought (open market) | +3K | added 50% | 8K | $9K at $3.62 | Nov 17, 25 |
Golden Arthur F Director | Bought (open market) | +20K 0.07% of company | added 100% | 30K | $100K at $4.95 | Oct 23, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on TTRX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
TTRX last traded at $14.94, up 8.10% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Turn Therapeutics Inc. Common Stock (TTRX) is next expected to report earnings on Thursday, November 12, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The TTRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TTRX 22 times in the last 30 days.
TTRX (Turn Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $454M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TTRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TTRX discussion
Sign in to ask a question or join the discussion.